NephrosSTU:NPJP +2.07%46 Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus rates STU:NPJP with a GF Score™ of 46/100 and a GF Value™ of €2.40 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Nephros ranks worse than 288184.15% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Nephros's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:NPJP vs MLSS, RGNT, HBIO: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Nephros's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephros Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nephros's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Nephros's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephros (STU:NPJP) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nephros and its competitors. According to the industry distribution chart, Nephros ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Nephros' Buyback Yield % too high?
Nephros' current Buyback Yield % is 0.00. Based on the distribution chart, Nephros ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nephros has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nephros' Buyback Yield % compare to MLSS and RGNT?
According to the Medical Devices & Instruments industry distribution chart, Nephros ranks #999999 out of 347 companies for Buyback Yield %. This places Nephros in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nephros and its competitors. Nephros's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephros stock overvalued right now?
Based on GuruFocus' analysis, Nephros (STU:NPJP) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.40, compared to a current price of €2.96 — trading 23.3% above its estimated fair value. The current Buyback Yield % is 0.00. Nephros' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Nephros (STU:NPJP), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nephros (STU:NPJP) Overvalued in 2026?
Based on GuruFocus' analysis, Nephros stock appears to be overvalued.
The current stock price of €2.96 is trading 23.3% above its estimated GF Value™ of €2.40.
GuruFocus considers Nephros to be Modestly Overvalued.
Key valuation signals for STU:NPJP:
Buyback Yield %: 0.00
GF Value™: €2.40 vs. price of €2.96 (23.3% above fair value)
No single metric tells the full story. See the STU:NPJP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
46GF Score
Get the complete analysis for STU:NPJP
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:NPJP has been successfully added to your 
